HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poised For IPO, Coty Bills Itself As Emerging “Multi-Segment” Beauty Firm

This article was originally published in The Rose Sheet

Executive Summary

After failing to acquire Avon and calling off a planned IPO in 2012, Coty once again prepares to go public, targeting $700 million in funding.

You may also be interested in...



P&G Streamlining Could Cut $12 Billion Beauty Slice To Coty

Coty could growing its global beauty presence significantly by acquiring P&G's Wella and Clairol hair-care businesses, CoverGirl and Max Factor makeup lines and prestige fragrance licenses in a deal rumored to be in the works.

P&G Streamlining Could Cut $12 Billion Beauty Slice To Coty

Coty could growing its global beauty presence significantly by acquiring P&G's Wella and Clairol hair-care businesses, CoverGirl and Max Factor makeup lines and prestige fragrance licenses in a deal rumored to be in the works.

P&G Beauty Businesses Could Be Going Coty's Way, Insiders Say

Coty could soon be the new owner of P&G's Wella and Clairol hair-care businesses, CoverGirl and Max Factor makeup lines and prestige fragrance licenses, significantly growing Coty's global beauty presence, under a deal rumored to be in the works. Coty's stock jumped nearly 15% following reports that it has won an auction to purchase the brands as part of P&G's streamlining initiative.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018538

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel